Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB711 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
	3	+	SB711 HFLR Page 1
	4	+	BOLD FACE denotes Committee Amendments. 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
3	28
4		-	An Act
5		-	ENROLLED SENATE
	29	+	HOUSE OF REPRESENTATIVES - FLOOR VERSION
	30	+
	31	+	STATE OF OKLAHOMA
	32	+
	33	+	1st Session of the 59th Legislature (2023)
	34	+
	35	+	ENGROSSED SENATE
6	36		BILL NO. 711 By: Rosino of the Senate
7	37
8	38		and
9	39
10	40		Boatman of the House
11	41
12	42
13	43
14	44
15	45		An Act relating to substance abuse services; defining
16	46		term; requiring the Department of Mental Health and
17	47		Substance Abuse Services to provide emergency opioid
18	48		antagonists to the Department of Corrections and
19	49		county jails subject to certain condition ; requiring
20	50		the Department of Mental Health and Substance Abuse
21	51		Services to prepare and provide opioid overdose
22	52		education program; describing program; amending 57
23	53		O.S. 2021, Section 4.1, which relates to prisons and
24	54		reformatories; requiring the Department of
25	55		Corrections and county jails to provide emergency
26	56		opioid antagonists to certain persons upon discharge
27	57		subject to certain condition; authorizing stocking
28	58		and provision of emergency opioid antagonists;
29	59		requiring provision of opioid overdose education
30	60		program to certain persons; providing certain
31	61		construction; providing for codification; and
32	62		providing an effective date.
33	63
34	64
35	65
36	66
37		-	SUBJECT: Substance abuse services
38		-
39	67		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
40		-
41	68		SECTION 1. NEW LAW A new section of law to be codified
42	69		in the Oklahoma Statutes as Section 2-401.1 of Title 43A, unless
43	70		there is created a duplication i n numbering, reads as follo ws:
44	71
	72	+	SB711 HFLR Page 2
	73	+	BOLD FACE denotes Committee Amendments. 1
	74	+	2
	75	+	3
	76	+	4
	77	+	5
	78	+	6
	79	+	7
	80	+	8
	81	+	9
	82	+	10
	83	+	11
	84	+	12
	85	+	13
	86	+	14
	87	+	15
	88	+	16
	89	+	17
	90	+	18
	91	+	19
	92	+	20
	93	+	21
	94	+	22
	95	+	23
	96	+	24
	97	+
45	98		A. As used in this section, “emergency opioid antagonist” means
46	99		a drug including but not limited to naloxone that blocks the effects
47		-
48		-	ENR. S. B. NO. 711 Page 2
49	100		of opioids and that is approved by the United Sta tes Food and Drug
50	101		Administration for the treat ment of an opioid overdose .
51		-
52	102		B. Subject to allocation of federal funding for the purchase of
53	103		emergency opioid antagonists, the Department of Mental Health and
54	104		Substance Abuse Services shall provide emergency opioid antagonists
55	105		to the Department of Corrections and to county jails for the purpose
56	106		of implementing Section 2 of this act.
57		-
58	107		C. The Department of Mental Health and Substance Abuse Services
59	108		shall prepare and provide an opioid overd ose education program to
60	109		the Department of Corrections and to county jails for the purpose of
61	110		implementing Section 2 of this act. The education program shall:
62		-
63	111		1. Conform to guidelines of the Substance Abuse and Mental
64	112		Health Services Administration for opioid overdose education ;
65		-
66	113		2. Explain the causes of an opioid overdose;
67		-
68	114		3. Instruct when and how to administer in accordance with
69	115		medical best practices:
70		-
71	116		a. life-saving rescue techniques , and
72		-
73	117		b. an emergency opioid antagonist;
74		-
75	118		4. Explain how to contact appropriate emergency medi cal
76	119		services; and
77		-
78	120		5. Provide information on how to access emergency opioid
79	121		antagonists.
80	122
	123	+	SB711 HFLR Page 3
	124	+	BOLD FACE denotes Committee Amendments. 1
	125	+	2
	126	+	3
	127	+	4
	128	+	5
	129	+	6
	130	+	7
	131	+	8
	132	+	9
	133	+	10
	134	+	11
	135	+	12
	136	+	13
	137	+	14
	138	+	15
	139	+	16
	140	+	17
	141	+	18
	142	+	19
	143	+	20
	144	+	21
	145	+	22
	146	+	23
	147	+	24
	148	+
81	149		SECTION 2. AMENDATORY 57 O.S. 2021, Section 4.1, is
82	150		amended to read as follo ws:
83		-
84	151		Section 4.1. A. In addition to other medical and health car e
85	152		services required by a jail facility as may be provided by rule by
86	153		the State Department of Health, the person responsible for
87	154		administration for a jail shall administer medi cations according to
88	155		the following:
89		-
90		-
91		-	ENR. S. B. NO. 711 Page 3
92	156		1. Prescription medications shall be provide d to the prisoner
93	157		as directed by a physician o r designated medical authority. The
94	158		prisoner shall be observed to ensure the prisoner takes the
95	159		medication. The physician or designated medical authority shall be
96	160		particularly aware through his or her trainin g of the impact of
97	161		opiate or methadone withdra wal symptoms that may occur in regard to
98	162		the mental and physical health of the prisoner. The physician or
99	163		medical authority shal l prescribe and administer appropriate
100	164		medications to the prisoner pursuant to Se ction 5-204 of Title 43A
101	165		of the Oklahoma Statu tes as the medical authority deems appropriate
102	166		to address those symptoms. Neither prescription nor over -the-
103	167		counter medications shall be kept by a prisoner in a cell with the
104	168		exception of prescribed nitroglyce rin tablets and prescription
105	169		inhalers. Over-the-counter medications shall not be administered
106	170		without a physician’s approval unless using prepackaged med ications;
107	171
	172	+	SB711 HFLR Page 4
	173	+	BOLD FACE denotes Committee Amendments. 1
	174	+	2
	175	+	3
	176	+	4
	177	+	5
	178	+	6
	179	+	7
	180	+	8
	181	+	9
	182	+	10
	183	+	11
	184	+	12
	185	+	13
	186	+	14
	187	+	15
	188	+	16
	189	+	17
	190	+	18
	191	+	19
	192	+	20
	193	+	21
	194	+	22
	195	+	23
	196	+	24
	197	+
108	198		2. Medical reception information shall be recorded on a printed
109	199		screening form approved by the physician or designated medical
110	200		authority which shall include inquiry into:
111		-
112	201		a. current illnesses and health problems including
113	202		medications taken and a ny special health req uirements,
114		-
115	203		b. behavioral observation, including state of
116	204		consciousness and mental status,
117		-
118	205		c. body deformities and trauma markin gs such as bruises,
119	206		lesions, jaundice, and ease of body movement,
120		-
121	207		d. condition of skin and visible body orif ices, including
122	208		infestations, and
123		-
124	209		e. disposition or referral of prisoners to qualified
125	210		medical personnel on an emergency basis; and
126		-
127	211		3. For purposes of this section, “physician or other licensed
128	212		medical personnel” means a psychiatrist, medical doctor, oste opathic
129	213		physician, physician’s assistant, registered nurse, licensed
130	214		practical nurse, emergency medica l technician at the paramedical
131	215		level or clinical nurse specialist.
132		-
133		-
134		-	ENR. S. B. NO. 711 Page 4
135	216		B. 1. Subject to the provision of emergency opioid antagonists
136	217		by the Department of Mental Hea lth and Substance Abuse Services
137	218		under Section 1 of this act:
138		-
139	219		a. the Department of Corrections, upon the discharge of
140	220		an inmate from an institution within the Department
141	221		who has been diagnosed with an opioid use disorder,
	222	+
	223	+	SB711 HFLR Page 5
	224	+	BOLD FACE denotes Committee Amendments. 1
	225	+	2
	226	+	3
	227	+	4
	228	+	5
	229	+	6
	230	+	7
	231	+	8
	232	+	9
	233	+	10
	234	+	11
	235	+	12
	236	+	13
	237	+	14
	238	+	15
	239	+	16
	240	+	17
	241	+	18
	242	+	19
	243	+	20
	244	+	21
	245	+	22
	246	+	23
	247	+	24
	248	+
142	249		regardless of whether tha t inmate has received
143	250		treatment for the disorder, shall provide the inmate ,
144	251		as the inmate leaves the institution, with two doses
145	252		of an emergency opioid antagonist, and
146		-
147	253		b. a county jail:
148		-
149	254		(1) upon the discharge of any person who is confined
150	255		in the jail pursuant to a sentence who has been
151	256		diagnosed with an opioid use disorder , regardless
152	257		of whether that person has received treatment for
153	258		the disorder, or
154		-
155	259		(2) upon the discharge of any person who is confined
156	260		in the jail for an offense related to possession
157	261		of an opioid drug other than:
158		-
159	262		(a) a person who is confined in the jail
160	263		pursuant to a sentence, or
161		-
162	264		(b) a person who is being transferred to th e
163	265		custody of the Department of Co rrections,
164		-
165	266		shall provide the person, as the person leaves the
166	267		jail, with two doses of an emergency opioid
167	268		antagonist.
168		-
169	269		2. Notwithstanding the provision of emergency opioid
170	270		antagonists by the Department of Mental Health and Substance Ab use
171	271		Services as provided by Section 1 of this act, the Department of
172	272		Corrections and county jails may stock and provide emergency opioid
	273	+
	274	+	SB711 HFLR Page 6
	275	+	BOLD FACE denotes Committee Amendments. 1
	276	+	2
	277	+	3
	278	+	4
	279	+	5
	280	+	6
	281	+	7
	282	+	8
	283	+	9
	284	+	10
	285	+	11
	286	+	12
	287	+	13
	288	+	14
	289	+	15
	290	+	16
	291	+	17
	292	+	18
	293	+	19
	294	+	20
	295	+	21
	296	+	22
	297	+	23
	298	+	24
	299	+
173	300		antagonists to inmates or persons upon discharge from the
174	301		institution or jail as described in paragraph 1 of this subse ction.
175		-
176		-
177		-	ENR. S. B. NO. 711 Page 5
178	302		3. Before the Department of Corrections or a county jail
179	303		provides an emergency opioid antagonist to a n inmate or person as
180	304		described in paragraph 1 or 2 of this subsection, the Department of
181	305		Corrections or the jail shall ensure that the in mate or person is
182	306		provided with the opioid overdose education program provided by the
183	307		Department of Mental Health and Substance Abuse Services under
184	308		Section 1 of this act.
185		-
186	309		4. Nothing in this subsection is intended to a brogate or
187	310		supersede any existing authority of the Department of Corrections or
188	311		a county jail to administer an emergency opioid antagonist to a
189	312		person experiencing an opioid overdose.
190		-
191	313		SECTION 3. This act shall become effective November 1, 2023.
192	314
193		-
194		-	ENR. S. B. NO. 711 Page 6
195		-	Passed the Senate the 8th day of March, 2023.
196		-
197		-
198		-
199		-	Presiding Officer of the Senate
200		-
201		-
202		-	Passed the House of Representatives the 19th day of April, 2023.
203		-
204		-
205		-
206		-	Presiding Officer of the House
207		-	of Representatives
208		-
209		-	OFFICE OF THE GOVERNOR
210		-	Received by the Office of the Governor this _______ _____________
211		-	day of _________________ __, 20_______, at _______ o'clock _______ M.
212		-	By: _______________________________ __
213		-	Approved by the Governor of the State of Oklahoma this _____ ____
214		-	day of _________________ __, 20_______, at _______ o'clock _______ M.
215		-
216		-	_________________________________
217		-	Governor of the State of Oklahoma
218		-
219		-
220		-	OFFICE OF THE SECRETARY OF STATE
221		-	Received by the Office of the Secretary of State this _______ ___
222		-	day of __________________, 20 _______, at _______ o'clock _______ M.
223		-	By: _______________________________ __
	315	+	COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 04/06/2023 -
	316	+	DO PASS.